Medical Condition News

RSS

Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

Sigma Tau Pharma Ltd. (hereinafter referred to as Sigma-Tau Rare Disease), today announced the submission of an application to the European Medicines Agency for use of its pegylatedL-asparaginase, Oncaspar (pegaspargase) for the treatment of Acute Lymphoblastic Leukaemia (ALL) as part of a multi-agent chemotherapeutic regimen.

10 Jul 2014

LA BioMed researchers launch new project to improve diabetes management

Managing diabetes is a year-round challenge for anyone living with the disease. The challenge is even greater for underserved and uninsured people who often don't have easy access to the care they need to manage their diabetes.

10 Jul 2014

Lower back pain not triggered by weather changes according to new study

Episodes of lower back pain are not triggered by changes in weather conditions, say Australian researchers.

10 Jul 2014

National Psoriasis Foundation to double the number of researchers studying psoriasis

National Psoriasis Foundation will double the number of researchers studying psoriasis and psoriatic arthritis while also cutting in half the number of people who say these chronic conditions are a problem in their daily lives as part of its new five-year strategic plan and mission to cure psoriatic disease and improve the lives of those affected.

10 Jul 2014

NCRI: Broader age limits can allow more teenage patients to take part in cancer trials

Age limits on clinical trials need to be more flexible to allow more teenage cancer patients the chance to access new treatments, according to a report from the National Cancer Research Institute (NCRI), published in the Lancet Oncology.

10 Jul 2014

Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma

Can-Fite BioPharma Ltd., a biotechnology company with a pipeline of proprietary small molecule drugs that address inflammatory and cancer diseases, announced today that the Israeli Ministry of Health has approved the use of its drug CF102 for a patient with hepatocellular carcinoma, the most common form of liver cancer, under the country's Compassionate Use Program.

10 Jul 2014

Medical treatment guidelines for diabetes

Medical treatment guidelines are suggestions that international organizations such as the American Diabetes Association, the European Society for the Study of Diabetes and the American Association of Clinical Endocrinologists, used to set the tone in the control of the disease and how to apply a better therapy, depending on the physical condition of the person.

10 Jul 2014

Allergy & Asthma Network, ALAA to increase awareness on life-threatening latex allergies

Allergy & Asthma Network, a leading nonprofit patient education organization, is pleased to announce that its Anaphylaxis Community Expert (ACE) volunteer program is partnering with the American Latex Allergy Association (ALAA) to increase awareness about life-threatening latex allergies.

10 Jul 2014

New knowledge may expand treatments for patients with lung cancer

Studying the most common type of lung cancer, researchers have uncovered mutations in a cell-signaling pathway that plays a role in forming tumors.

10 Jul 2014

New drug could prove useful in treating small cell lung cancer

Manchester scientists have shown that a new drug could prove useful in treating small cell lung cancer - the most aggressive form of lung cancer.

From The University of Manchester 10 Jul 2014

People can be conditioned to feel less pain when they hear neutral sound

People can be conditioned to feel less pain when they hear a neutral sound, new research from the University of Luxembourg has found. This lends weight to the idea that we can learn to use mind-over-matter to beat pain. The scientific article was published recently in the online journal "PLOS One".

10 Jul 2014

New class of anti-arthritic drugs reduce arthritic joint inflammation and periodontitis

Inflammatory diseases can occur simultaneously in distinct sites in the same patient, complicating treatment because a medication effective for one disorder may exacerbate the other.

10 Jul 2014

Study reveals effect of 3-n-butylphthalide on chronic ischemic stroke

The pathogenesis of vascular dementia induced by chronic cerebral ischemia is complex, mainly consisting of energy metabolism disorder, oxidative stress injury, neuronal apoptotic cell death and cholinergic nerve dysfunction.

10 Jul 2014

Study examines use of electronic patient portals by patients with cancer

There has been a sharp increase in the number of cancer patients at UT Southwestern Medical Center using MyChart, the online, interactive service that allows patients to view laboratory and radiology results, communicate with their healthcare providers, schedule appointments, and renew prescriptions.

10 Jul 2014

Parkinson's disease drug could also help people with phobias or PTSD

A drug used to treat Parkinson's disease could also help people with phobias or post-traumatic stress disorder (PTSD). Scientists of the Translational Neurosciences Research Center at Johannes Gutenberg University Mainz are currently exploring the effects of psychotherapy to extinguish fears in combination with L-dopa.

10 Jul 2014

Study evaluates investigational drug for moderate to severe endometriosis pain symptoms

Most women know all too well the temporary discomfort associated with menstrual cramps. Women with endometriosis, however, suffer with pain that can be debilitating —not just during their period, but sometimes even during other times of the month.

10 Jul 2014

Research into cell metabolism could open new therapeutic avenues for diabetes, cancer

More scientific research into the metabolism of stromal support cells and immune cells - and the role of the metabolism of these cell types in the development of diseases - could open new therapeutic avenues for diabetes, inflammatory conditions and cancer. That was the conclusion of a review article by scientists from VIB and KU Leuven in the leading journal Nature.

10 Jul 2014

TCGA finds novel mutations in key cancer-causing pathway in lung adenocarcinoma

Researchers from The Cancer Genome Atlas Research Network have identified novel mutations in a well-known cancer-causing pathway in lung adenocarcinoma, the most common subtype of lung cancer.

10 Jul 2014

Research uncovers how complex protein pivotal in cancer development is activated

New research has uncovered how a complex protein pivotal in the development of cancer, viral infection and autoimmune diseases is activated.

10 Jul 2014

Daily temperatures increase number of patients seeking treatment for kidney stones

As daily temperatures increase, so does the number of patients seeking treatment for kidney stones. In a study that may both reflect and foretell a warming planet's impact on human health, a research team found a link between hot days and kidney stones in 60,000 patients in several U.S. cities with varying climates.

10 Jul 2014

Medical Condition News

Sigma-Tau Rare Disease seeks EMA approval for use of Oncaspar for ALL treatment

LA BioMed researchers launch new project to improve diabetes management

Lower back pain not triggered by weather changes according to new study

National Psoriasis Foundation to double the number of researchers studying psoriasis

NCRI: Broader age limits can allow more teenage patients to take part in cancer trials

Can-Fite's CF102 drug gets approval in Israel for patient with hepatocellular carcinoma

Medical treatment guidelines for diabetes

Allergy & Asthma Network, ALAA to increase awareness on life-threatening latex allergies

New knowledge may expand treatments for patients with lung cancer

New drug could prove useful in treating small cell lung cancer

People can be conditioned to feel less pain when they hear neutral sound

New class of anti-arthritic drugs reduce arthritic joint inflammation and periodontitis

Study reveals effect of 3-n-butylphthalide on chronic ischemic stroke

Study examines use of electronic patient portals by patients with cancer

Parkinson's disease drug could also help people with phobias or PTSD

Study evaluates investigational drug for moderate to severe endometriosis pain symptoms

Research into cell metabolism could open new therapeutic avenues for diabetes, cancer

TCGA finds novel mutations in key cancer-causing pathway in lung adenocarcinoma

Research uncovers how complex protein pivotal in cancer development is activated

Daily temperatures increase number of patients seeking treatment for kidney stones

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News